NURESCA

Welcome to the Brand page for “NURESCA”, which is offered here for In the statement, column 1 lines 5 and 6, cardiovascular disease should be deleted.;pharmaceutical preparations for the treatment of [ cardiovascular disease, ] infectious diseases, and immunological, viral disorders;.

Its status is currently believed to be active. Its class is unavailable. “NURESCA” is believed to be currently owned by “Pfizer Inc.”


Owner:
PFIZER INC.
Owner Details
Description:
In the statement, column 1 lines 5 and 6, CARDIOVASCULAR DISEASE should be deleted.;Pharmaceutical preparations for the treatment of [ cardiovascular disease, ] infectious diseases, and immunological, viral disorders;
Categories: STATEMENT